|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net (loss) income to net cash provided by continuing operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of debt issuance costs | |||||
| Equity-based compensation expense | |||||
| Deferred income taxes | |||||
| Legal settlements expense | |||||
| Non-cash legal settlements expense | |||||
| Loss on impairment | |||||
| Gain on sale of property | |||||
| Other | |||||
| Change in operating assets and liabilities, net of effect of acquisitions: | |||||
| Accounts receivable, net | |||||
| Other current assets | |||||
| Other assets | |||||
| Accounts payable and other accrued liabilities | |||||
| Accrued salaries and benefits | |||||
| Other liabilities | |||||
| Government relief funds | |||||
| Net cash provided by continuing operating activities | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Cash paid for acquisitions, net of cash acquired | |||||
| Cash paid for capital expenditures | |||||
| Proceeds from sale of property and equipment | |||||
| Other | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Borrowings on long-term debt | |||||
| Borrowings on revolving credit facility | |||||
| New Credit Facility | |||||
| Principal payments on revolving credit facility | |||||
| Total principal payments on revolving credit facility | |||||
| Principal payments on long-term debt | |||||
| Repayment of long-term debt | |||||
| Payment of debt issuance costs | |||||
| Distributions to noncontrolling interests | |||||
| Repurchase of shares for payroll tax withholdings, net of proceeds from stock option exercises | |||||
| Repurchase of common stock | |||||
| Contributions from noncontrolling partners in joint ventures | |||||
| Distributions to noncontrolling partners in joint ventures | |||||
| Cash paid for contingent consideration | |||||
| Other | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of the period | |||||
| Cash and cash equivalents at end of the period | |||||
| Supplemental Cash Flow Information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Effect of acquisitions: | |||||
| Assets acquired, excluding cash | |||||
| Liabilities assumed | |||||
| Contingent consideration issued in connection with an acquisition | |||||
| Redeemable noncontrolling interest resulting from an acquisition | |||||
Loading...